Mass General Brigham, Inc 13F Portfolio

CIK 1678378 Filing since Q2 2021 Q2 2026 filed Aug 6, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 6, 2026.

Portfolio Snapshot

5 positions · Q2 2026

Mass General Brigham, Inc reported 5 positions worth $163.35M for the quarter ended Jun 30, 2026, down 7.3% on the prior quarter. It opened 0 new positions, added to 0, trimmed 1 and exited 0. Its largest holding is Karman Holdings Inc. at 47.7% of the portfolio.

Portfolio Value
$163.35M
-7.3% QoQ · — YoY
Positions
5
0 new · 0 sold out
Top 10 Concentration
100%
of portfolio value
Largest Position
KRMN 47.7%
Karman Holdings Inc.
Net Buying
-$76.67K
$0.00 bought · $76.67K sold
Turnover
0%
of the portfolio traded
Top Sector
Healthcare
52.3% of value
Track Record
17
quarters on file since Q2 2021

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

2 sectors
52.26%
Healthcare
Healthcare52.26%
Industrials47.74%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

HealthcareIndustrialsTechnologyConsumer DiscretionaryEnergy

Largest Buys

Q2 2026

No positions were added to this quarter.

Largest Sells

Q2 2026
Holding Change Change % Trade Value Weight
MDLN Medline Inc. -1,944 -2.8% $76.67K 1.65%

New Positions

Q2 2026

No new positions this quarter.

Closed Positions

Q2 2026

No positions were closed this quarter.

Holdings · Q2 2026

5 Positions

As ofJun 30, 2026
Value$163.35M
Top 10100%
Avg position$32.67M
# Activity
Showing all 5 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Mass General Brigham.

About Mass General Brigham, Inc’s 13F Portfolio

What are Mass General Brigham, Inc’s largest holdings?

As of its Q2 2026 13F filing, Mass General Brigham, Inc’s five largest positions were Karman Holdings Inc. (KRMN) at 47.7%, Revolution Medicines, Inc. (RVMD) at 39.5%, Tango Therapeutics, Inc. (TNGX) at 6.8%, Maze Therapeutics, Inc. (MAZE) at 4.4%, Medline Inc. (MDLN) at 1.7% of the reported portfolio.

How much is Mass General Brigham, Inc’s portfolio worth?

Mass General Brigham, Inc reported a 13F portfolio worth $163.35M across 5 positions for Q2 2026. That is down 7.3% from the previous quarter.

What did Mass General Brigham, Inc sell in Q2 2026?

Its largest sales by value were Medline Inc. ($76.67K). It exited 0 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Mass General Brigham, Inc files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.